Bioprocess Validation Market

The bioprocess validation market involves ensuring that biopharmaceutical manufacturing processes consistently meet predefined quality standards and regulatory requirements. Key customers include pharmaceutical companies, Contract Development & Manufacturing Organizations (CDMOs), and biotechnology firms. The market's growth is primarily driven by the increasing demand for biologics and biosimilars, stringent regulatory mandates like Good Manufacturing Practices (GMP), and advancements in bioprocessing technologies.